BridgeMD
New treatment option for Postoperative Pain
Official title Erector Spinae Plane Block and Low-Flow Anaesthesia in Laparoscopic Cholecystectomy
ClinicalTrials.gov ID: NCT07653490
What this study is testing
What is Bupivacaine?
Bupivacaine is an investigational medicine, given as an inhaled treatment, being studied as a potential treatment for postoperative pain.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This prospective randomized controlled study aims to evaluate the effects of preoperative ultrasound-guided erector spinae plane (ESP) block combined with low-flow anaesthesia on postoperative quality of recovery and opioid consumption in patients undergoing elective laparoscopic cholecystectomy. The study will compare postoperative recovery quality, pain scores, analgesic requirements, and perioperative outcomes between patients receiving ESP block with low-flow anaesthesia and those receiving standard anaesthetic management.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Patients aged 18-65 years
- ASA physical status I-II
- Body mass index (BMI) \<35 kg/m²
- Scheduled for elective laparoscopic cholecystectomy
- Ability to provide written informed consent
You likely can't join if
- Coagulopathy or bleeding disorders
- Allergy to local anaesthetic agents
- Infection at the block application site
- Neurological or psychiatric disorders
- Communication difficulties
- Chronic opioid or analgesic use
See the full eligibility criteria
- Patients aged 18-65 years
- ASA physical status I-II
- Body mass index (BMI) \<35 kg/m²
- Scheduled for elective laparoscopic cholecystectomy
- Ability to provide written informed consent
- Coagulopathy or bleeding disorders
- Allergy to local anaesthetic agents
- Infection at the block application site
- Neurological or psychiatric disorders
- Communication difficulties
- Chronic opioid or analgesic use
- Reoperation cases
- Acute cholecystitis
- Conversion to open surgery
- Inadequate dermatomal block after ESPB
- Severe intraoperative hemodynamic instability
- Intraoperative blood loss ≥250 mL
- Development of allergic reactions or major complications during follow-up
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.